Literature DB >> 16166784

Epidemiology of hepatitis C virus in Korea.

Hai-Rim Shin1.   

Abstract

Mortality due to liver cancer in Korea ranks as one of the highest in the world. Both hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are high-risk factors for liver cancer. Although HBV is by far the more important risk factor for the development of hepatocellular carcinoma (HCC) in Korea, HCV infection is more closely associated with HCC in elderly patients. Therefore, the evaluation of risk factors for HCV infection, including blood transfusion, is important. This study reviews the literature on HCV prevalence and risk factors among the general population, as well as the distribution of HCV genotypes in Korea. An overall estimate of the prevalence of anti-HCV among Koreans older than 40 years was 1.29% (95% confidence interval 1.12-1.48) during 1995-2000. Blood transfusion was the strongest risk factor for transmission of HCV infection. Risk factors for HCV infection in Korea other than blood transfusion and history of acupuncture have not been proven. The most prevalent HCV genotype is 1b followed by 2a. Even though the prevalence of anti-HCV in Korea has been reduced and the risk of HCV transmission through blood transfusion has markedly decreased, public-health programs to prevent de novo infections should be developed. Moreover, most people infected with HCV in Korea are older than 40 years, and therefore, the surveillance of adults (> or =40 years) for HCV infection will be helpful in early detection of HCC developing in them. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16166784     DOI: 10.1159/000087258

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  25 in total

1.  Retreatment with peginterferon and ribavirin in chronic hepatitis C.

Authors:  Yong Min Jo; Sung Wook Lee; Sang Young Han; Yang Hyun Baek; Soo Young Kim; Woo Jae Kim; Ji Hye Ahn; Ji Young Lee
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 2.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

3.  Total cholesterol and cancer risk in a large prospective study in Korea.

Authors:  Cari M Kitahara; Amy Berrington de González; Neal D Freedman; Rachel Huxley; Yejin Mok; Sun Ha Jee; Jonathan M Samet
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

4.  Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea.

Authors:  E H Yun; M K Lim; J-K Oh; J H Park; A Shin; J Sung; E-C Park
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

5.  Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+.

Authors:  Scott Seronello; Chieri Ito; Takaji Wakita; Jinah Choi
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

6.  Behavioral and healthcare-associated risk factors for chronic hepatitis C virus infection in Korea.

Authors:  Jong Yeop Kim; Juhee Cho; Sung Ho Hwang; Ho Kil; Si Hyun Bae; Young Seok Kim; Han Chu Lee; Sook-Hyang Jeong
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

7.  Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience.

Authors:  Eun Ju Cho; Su Hyeon Jeong; Byung Hoon Han; Sang Uk Lee; Byung Chul Yun; Eun Taek Park
Journal:  Clin Mol Hepatol       Date:  2012-06-26

8.  A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.

Authors:  Byung Chul You; Young Seok Kim; Hun il Kim; Se Hun Kim; Seung Sik Park; Yu Ri Seo; Sang Gyune Kim; Se Whan Lee; Hong Soo Kim; Soung Won Jeong; Jae Young Jang; Boo Sung Kim
Journal:  Clin Mol Hepatol       Date:  2012-09-25

9.  Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.

Authors:  Jin-Kyoung Oh; Hai-Rim Shin; Min Kyung Lim; Heeyoun Cho; Dong-Il Kim; Youngmee Jee; Haesun Yun; Keun-Young Yoo
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

10.  Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea.

Authors:  Younghee Jung; Myung Jin Lee; Hye-Yun Sin; Nak-Hyun Kim; Jeong-Hwan Hwang; Jinyong Park; Pyoeng Gyun Choe; Wan Beom Park; Eu Suk Kim; Sang-Won Park; Kyoung Un Park; Hong Bin Kim; Nam-Joong Kim; Eui-Chong Kim; Kyoung-Ho Song; Myoung-Don Oh
Journal:  BMC Infect Dis       Date:  2012-10-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.